Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 35640802)

  • 1. Active targeting redox-responsive mannosylated prodrug nanocolloids promote tumor recognition and cell internalization for enhanced colon cancer chemotherapy.
    Gao Y; Qiu W; Liang M; Ma X; Ye M; Xue P; Kang Y; Deng J; Xu Z
    Acta Biomater; 2022 Jul; 147():299-313. PubMed ID: 35640802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox-responsive amphiphilic camptothecin prodrug nanoparticles for targeted liver tumor therapy.
    Lu L; Li B; Lin C; Li K; Liu G; Xia Z; Luo Z; Cai K
    J Mater Chem B; 2020 May; 8(17):3918-3928. PubMed ID: 32227058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redox/pH dual-stimuli responsive camptothecin prodrug nanogels for "on-demand" drug delivery.
    Qu Y; Chu B; Wei X; Lei M; Hu D; Zha R; Zhong L; Wang M; Wang F; Qian Z
    J Control Release; 2019 Feb; 296():93-106. PubMed ID: 30664976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox-responsive nanoparticles based on Chondroitin Sulfate and Docetaxel prodrug for tumor targeted delivery of Docetaxel.
    Li Y; Chen X; Ji J; Li L; Zhai G
    Carbohydr Polym; 2021 Mar; 255():117393. PubMed ID: 33436222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular delivery and antitumor effects of a redox-responsive polymeric paclitaxel conjugate based on hyaluronic acid.
    Yin S; Huai J; Chen X; Yang Y; Zhang X; Gan Y; Wang G; Gu X; Li J
    Acta Biomater; 2015 Oct; 26():274-85. PubMed ID: 26300335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A redox-responsive dihydroartemisinin dimeric nanoprodrug for enhanced antitumor activity.
    Li Y; Pei Q; Cui B; Zhang H; Han L; Li W; Zhu W; Feng X; Xie Z
    J Nanobiotechnology; 2021 Dec; 19(1):441. PubMed ID: 34930288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversibly "double locked" hydroxycamptothecin prodrug nanoparticles for targeted chemotherapy of lung cancer.
    Zhang J; Wang B; Wang H; Wang Z; Zhang P; Huang X; Qian H; Huang D; Chen W; Zhong Y
    Acta Biomater; 2023 Aug; 166():593-603. PubMed ID: 37220820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RGD peptide modified platinum nanozyme Co-loaded glutathione-responsive prodrug nanoparticles for enhanced chemo-photodynamic bladder cancer therapy.
    Hao Y; Chen Y; He X; Han R; Yang C; Liu T; Yang Y; Liu Q; Qian Z
    Biomaterials; 2023 Feb; 293():121975. PubMed ID: 36580720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic core crosslinked camptothecin prodrug micelles with reduction sensitivity and boronic acid-mediated enhanced endocytosis: An intelligent tumor-targeted delivery nanoplatform.
    Huang Y; Zhang W; Xu Y; Zhu S; Wu Y; Chen T; Xiao Y; Lu W; Zhang X; Yu J
    Int J Pharm; 2020 Apr; 580():119250. PubMed ID: 32209369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy.
    Sun B; Luo C; Yu H; Zhang X; Chen Q; Yang W; Wang M; Kan Q; Zhang H; Wang Y; He Z; Sun J
    Nano Lett; 2018 Jun; 18(6):3643-3650. PubMed ID: 29726685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox-Responsive and Dual-Targeting Hyaluronic Acid-Methotrexate Prodrug Self-Assembling Nanoparticles for Enhancing Intracellular Drug Self-Delivery.
    Zhang Y; Li Y; Tian H; Zhu Q; Wang F; Fan Z; Zhou S; Wang X; Xie L; Hou Z
    Mol Pharm; 2019 Jul; 16(7):3133-3144. PubMed ID: 31198046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocytosis-mediated triple-activable prodrug nanotherapeutics potentiating therapeutic efficacy and security towards solid tumors.
    Fu S; Ma S; Peng X; Qiao H; Zang W; Ye J; Zang W; Li M; Shi K; Ye X; Sun W; Zhai Y
    Colloids Surf B Biointerfaces; 2022 Oct; 218():112723. PubMed ID: 35932558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pH-responsive prodrug delivery system of 10-HCPT for controlled release and tumor targeting.
    Liu Y; Li D; Guo X; Xu H; Li Z; Zhang Y; Song C; Fan R; Tang X; Zhang Z
    Int J Nanomedicine; 2017; 12():2227-2242. PubMed ID: 28356739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transferrin receptor-targeted redox/pH-sensitive podophyllotoxin prodrug micelles for multidrug-resistant breast cancer therapy.
    Li Y; Chen M; Yao B; Lu X; Zhang X; He P; Vasilatos SN; Ren X; Bian W; Yao C
    J Mater Chem B; 2019 Oct; 7(38):5814-5824. PubMed ID: 31495855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A robust strategy for preparation of sequential stimuli-responsive block copolymer prodrugs via thiolactone chemistry to overcome multiple anticancer drug delivery barriers.
    Ke W; Yin W; Zha Z; Mukerabigwi JF; Chen W; Wang Y; He C; Ge Z
    Biomaterials; 2018 Feb; 154():261-274. PubMed ID: 29149720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
    Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
    Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery.
    Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H
    Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy.
    Zou L; Liu X; Li J; Li W; Zhang L; Fu C; Zhang J; Gu Z
    Theranostics; 2021; 11(9):4171-4186. PubMed ID: 33754055
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor redox heterogeneity-responsive prodrug nanocapsules for cancer chemotherapy.
    Wang J; Sun X; Mao W; Sun W; Tang J; Sui M; Shen Y; Gu Z
    Adv Mater; 2013 Jul; 25(27):3670-6. PubMed ID: 23740675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facile construction of bioreducible crosslinked polypeptide micelles for enhanced cancer combination therapy.
    Ruttala HB; Chitrapriya N; Kaliraj K; Ramasamy T; Shin WH; Jeong JH; Kim JR; Ku SK; Choi HG; Yong CS; Kim JO
    Acta Biomater; 2017 Nov; 63():135-149. PubMed ID: 28890258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.